- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Chronic pain affects about half of people with multiple sclerosis (PwMS), and standard drug treatments often provide limited relief. Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week program that combines mindfulness practices with cognitive and behavioral coping skills and has shown positive effects on pain severity, pain interference, and pain catastrophizing in PwMS. However, daily home practice is essential to achieving these benefits, and adherence is poor. People with chronic pain complete less than 40 out of every 100 recommended practice sessions. PwMS face unique barriers to practice including pain, fatigue, cognitive difficulties, and mood changes that can fluctuate within a single day. Understanding what drives or interferes with daily practice in this population is critical to improving MBCT outcomes.
This single-arm trial is the first aim of a research project designed to develop and optimize a smartphone-based just-in-time adaptive intervention (JITAI) to support mindfulness practice in PwMS during MBCT for chronic pain (1K23AT013270-01A1, Mistretta, PI). In this aim, 80 PwMS will participate in an 8-week group-based MBCT program delivered via telehealth. Ecological momentary assessment (EMA), a method of collecting real-time self-report data via smartphone, will be used to capture emotional, physical, and environmental factors as they naturally occur in daily life. Participants will complete twice-daily EMA surveys using an EMA smartphone app for 1 week before the program, during the 8-week program, and for 1 week after the program ends. Patient-reported outcome measures will be collected before and after the program.
The primary outcome is whether a participant practiced mindfulness between each EMA survey. Secondary outcomes include minutes practiced, type of practice (formal or informal), and self-rated quality of practice. Time-varying predictors assessed via EMA include positive and negative affect, stress, pain severity, pain interference, fatigue, sleep, location, social context, and time of day. Time-invariant predictors assessed at baseline include pain severity, pain interference, fatigue, pain catastrophizing, dispositional mindfulness, sleep, self-efficacy, depression, and cognitive functioning.
Multilevel modeling will be used to account for the nested data structure (assessments within days, within participants). A two-part modeling approach will assess both whether practice occurred on a given day and, on days when practice did occur, how much practice was completed. Three sets of models will examine same-day, longitudinal, and lagged relationships between predictors and practice outcomes. Predictors demonstrating at least a medium within-person effect on mindfulness practice will be considered as tailoring variables for the JITAI developed in the next phase of this project.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Erin G Mistretta, PhD
- Número de telefone: 206-668-4168
- E-mail: emistr@uw.edu
Estude backup de contato
- Nome: Dawn Ehde, PhD
- Número de telefone: 206-744-2811
- E-mail: edhe@uw.edu
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Have an MS diagnosis of any subtype per record review
- Average pain intensity in past week of at least moderate severity (>3 on the 0-10 numerical rating scale)
- Report pain >50% of days in the past 6 months.
- Are able to comply with study procedures and complete measures independently via self-report (on mobile phone)
Exclusion Criteria:
- Less than 18 years of age
- Score greater than 8 on the Expanded Disability Status Scale
- Have significant cognitive impairment as indicated by 1 or more errors on the 6-item Cognitive Screener
- Change in disease modifying medications in the past 3 months assessed via self-report (although participants will be considered eligible after the 3-month window)
- History of MS relapse within the last 30 days prior to screening assessed via self-report (although participants will be considered eligible after the 3-month window)
- Current suicidal ideation with intent or plan as indicated by a score of 1 or higher on the Patient Health Questionnaire-9 suicide item and further assessment with the Columbia-Suicide Severity Rating Scale (although individuals with suicidal ideation but no intent or plan will be considered eligible)
- Currently engaged in psychotherapy for pain assessed via self-report
- Currently have a "regular" mindfulness practice defined as > 3 days per week assessed via self-report
- Inability to read or speak English
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Mindfulness-Based Cognitive Therapy (MBCT)
Participants will attend eight, 2-hour group treatment MBCT sessions delivered using free video-conferencing technology.
Groups will consist of 8-10 people who also have MS and chronic pain.
Participants will be asked to practice skills learned in session between sessions.
MBCT integrates mindfulness meditation practices within a CBT-oriented framework to address not only unhelpful pain cognitions and behaviors but also attentional control, decoupling of attention from emotion, mindful cognitions, and meditative behavior.
|
Participants will attend eight, 2-hour group treatment MBCT sessions delivered using free video-conferencing technology.
Groups will consist of 8-10 people who also have MS and chronic pain.
Participants will be asked to practice skills learned in session between sessions.
MBCT integrates mindfulness meditation practices within a CBT-oriented framework to address not only unhelpful pain cognitions and behaviors but also attentional control, decoupling of attention from emotion, mindful cognitions, and meditative behavior.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Daily Mindfulness Practice
Prazo: Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
Whether a participant engaged in any formal (for example, sitting meditation) or informal (for example, mindfully engaging in a daily task) mindfulness practice since the last check-in, assessed via a single yes or now question delivered twice daily through the smartphone app.
This will also be tracked passively by indicating whether participants accessed a guided meditation in the app itself.
|
Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Type of Mindfulness Practice
Prazo: Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
Whether the mindfulness practice completed since the last check-in was formal (for example, sitting meditation using a guided audio recording) or informal (for example, mindfully engaging in a daily task), assessed via a single multiple choice question delivered twice daily through the smartphone app.
|
Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
|
Quality of Mindfulness Practice
Prazo: Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
A participant's self-rated quality of their most recent mindfulness practice since the last check-in, assessed via the 1-item Practice Quality-Mindfulness (PQM) scale delivered twice daily through the smartphone app.
A higher score indicates higher self-report practice quality.
|
Twice daily for approximately 10 weeks (1 week before, 8 weeks during, and 1 week after the MBCT program)
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain Intensity
Prazo: Pre-intervention and post-intervention (approximately 10 weeks apart)
|
Participant-rated pain severity assessed via the 3-item Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity scale at pre- and post-intervention.
|
Pre-intervention and post-intervention (approximately 10 weeks apart)
|
|
Pain Interference
Prazo: Pre-intervention and post-intervention (approximately 10 weeks apart)
|
The degree to which pain limits a participant's daily activities and functioning, assessed via the 6-item Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference scale at pre- and post-intervention.
|
Pre-intervention and post-intervention (approximately 10 weeks apart)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Erin Mistretta, PhD, University of Washington
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- STUDY00023785
- 1K23AT013270-01A1 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em MBCT
-
NYU Langone HealthNational Center for Complementary and Integrative Health (NCCIH)Concluído
-
Lakehead UniversityOntario Neurotrauma FoundationConcluídoDepressão | Traumatismo crânianoCanadá
-
Amanda ShallcrossThe Cleveland Clinic; Wake Forest University Health Sciences; National Center... e outros colaboradoresAtivo, não recrutando
-
Radboud University Medical CenterAtivo, não recrutandoMal de ParkinsonHolanda
-
Massachusetts General HospitalNational Institute on Aging (NIA)ConcluídoDoença arterial coronária | Dorme | Ansiedade | Síndrome Coronariana AgudaEstados Unidos
-
Case Comprehensive Cancer CenterAtivo, não recrutandoCâncer de mama | Câncer de Mama Estágio I | Câncer de Mama Estágio II | Câncer de Mama Feminino | Câncer de Mama Estágio III | Depressão Moderada | Depressão leveEstados Unidos
-
Universidad de los Andes, ChileMinisterio de Educación, ChileAtivo, não recrutandoTranstornos de ansiedade | Estresse, Psicológico | Depressão UnipolarChile
-
Clemson UniversityPrisma Health-UpstateConcluídoTranstorno Depressivo MaiorEstados Unidos
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH); Emory University; Kaiser PermanenteConcluídoDepressão | Depressão pós-parto | GravidezEstados Unidos
-
British Columbia Children's HospitalAtivo, não recrutando